Clementia

YTD

ALL

Why Robinhood?

You can watch Clementia and buy or sell other stocks, ETFs, and their options commission-free!

About CMTA

Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases.

CEO

Clarissa Desjardins, PhD

CEOClarissa Desjardins, PhD

Employees

—

Employees—

Headquarters

Montréal, Québec

HeadquartersMontréal, Québec

Founded

2010

Founded2010

Employees

—

Employees—

CMTA Key Statistics

Market cap

997.72M

Market cap997.72M

Price-Earnings ratio

-14.92

Price-Earnings ratio-14.92

Dividend yield

—

Dividend yield—

Average volume

267.67K

Average volume267.67K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$26.73

52 Week high$26.73

52 Week low

$8.10

52 Week low$8.10